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Specialized cell types of trophoblast cells form the placenta in which each cell type has
particular properties of proliferation and invasion. The placenta sustains the growth of
the fetus throughout pregnancy and any aberrant trophoblast differentiation or invasion
potentially affects the future health of the child and adult. Recently, the field of epigenetics
has been applied to understand differentiation of trophoblast lineages and embryonic
stem cells (ESC), from fertilization of the oocyte onward. Each trophoblast cell-type has
a distinctive epigenetic profile and we will concentrate on the epigenetic mechanism of
DNA methyltransferases and TETs that regulate DNA methylation. Environmental factors
affecting the mother potentially regulate the DNA methyltransferases in trophoblasts, and
so do steroid hormones, cell cycle regulators, such as p53, and cytokines, especially
interlukin-1β. There are interesting questions of why trophoblast genomes are globally
hypomethylated yet specific genes can be suppressed by hypermethylation (in general,
tumor suppressor genes, such as E-cadherin) and how invasive cell-types are liable to
have condensed chromatin, as in metastatic cancer cells. Future work will attempt to
understand the interactive nature of all epigenetic mechanisms together and their effect
on the complex biological system of trophoblast differentiation and invasion in normal as
well as pathological conditions.
Keywords: DNA methyltransferases, trophoblasts, cell differentiation, TETs, placenta, chromatin condensation,
hydroxymethylation, epigenetics
EPIGENETIC MECHANISMS ARE INVOLVED IN DEVELOPING
A HEALTHY PLACENTA
The epigenetic mechanism of DNA methylation partially
regulates trophoblast differentiation and invasion into the
endometrium of the uterus in order to establish and maintain a
healthy placenta for the growing fetus. The placenta is an essential
organ for sustaining the life of the fetus through which nutrients,
oxygen exchange, immune barrier protection, and waste disposal
are achieved between the fetal and maternal blood circulations
(Cross et al., 1994; Arck and Hecher, 2013). Defective placenta-
tion and aberrant differentiation and invasion of the trophoblasts
potentially results in pathologies of pregnancy, which include
pre-eclampsia, intrauterine growth restriction (IUGR) (Maccani
and Carmen, 2009; Kokkinos et al., 2010), spontaneous abor-
tion, preterm birth (Khong and Brosens, 2011), placenta acreta,
“Hemolysis, Elevated Liver enzymes, Low Platelets” (HELLP)
(van Dijk et al., 2012), and choriocarcinoma (Graham and Lala,
1992; Norwitz, 2006). Environmental factors, such as diet and
oxygen stress, can adversely affect the epigenetic mechanisms that
the embryo relies on to implant and fully grow into a healthy
fetus (Yuen et al., 2013). Epigenetic mechanisms partially reg-
ulate extra-villous trophoblast differentiation and invasiveness
into the endometrium (Figure 1) (Rahnama et al., 2006; Rugg-
Gunn, 2012; Chen et al., 2013a). Over the last decade the study of
epigenetics has been applied to many complex biological systems,
such as trophoblast differentiation, in order to reach an under-
standing of the mechanisms and the pathways (Cox et al., 2009,
2011; Choi, 2010; Hemberger, 2010; Senner and Hemberger,
2010; Turner et al., 2012; Arnold et al., 2013).
DNA METHYLATION IS ONE OF SEVERAL EPIGENETIC
MECHANISMS
DNA methylation, histone modification and non-coding RNA
(ncRNA) and the interactions between them are some of the
epigenetic mechanisms that have been studied in the placenta
(Fuks et al., 2003; Nelissen et al., 2011). The field of epigenet-
ics is continually expanding and there is recent interest in DNA
hydroxymethylation and TET methylcytosine dioxygenases (ten-
eleven translocation) (Tahiliani et al., 2009; Dahl et al., 2011; Xu
et al., 2011; Zhao and Chen, 2013), and the role of various types of
ncRNA, such as micro RNAs (miRNA) (Tsai et al., 2009; Ji et al.,
2013; Mouillet et al., 2013) and long intergenic ncRNA (lincRNA)
(van Dijk et al., 2012). The three main DNMTs that methylate
cytosines in CpG dinucleotides to 5-methylcytosine (5mC) are
DNMT1, the maintenance methyltransferase, and the de novo
methyltransferases DNMT3A and DNMT3B, which each have
gene-specific methylation sites in distinct genomic DNA regions
(Hsieh, 1999; Okano et al., 1999; Takeshima et al., 2006). Another
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FIGURE 1 | Trophoblast stem cells differentiate into specialized
trophoblast cells.
member of the DNMT3 family is DNMT3L, which is essential
for placental development through establishing maternal gene
imprinting (Chédin et al., 2002; Hata et al., 2002; Arima et al.,
2006). Imprinting of paternal or maternal genes has an impor-
tant effect on placenta gene expression and subsequent growth
of the fetus (Reik and Walter, 2001; Wang et al., 2013a). DNA
methylation of CpGs generally silences a gene by at least three
different functions; the binding of transcription factors (Watt
and Molloy, 1988), attracting methyl binding domain proteins
(MBD) (Boyes and Bird, 1991), and altering chromatin pack-
aging (Ng and Bird, 1999). Moreover, DNMTs have both DNA
methylation-independent as well as methylation-dependent func-
tions (Bachman et al., 2001; Fuks et al., 2001; Esteve et al., 2005;
Pavlopoulou and Kossida, 2010). There are a few instances when
instead of repressing transcription, DNA methylation activates
transcription, but how this is achieved is still unknown, but
release of inhibitors is most likely (Gellersen and Kempf, 1990;
Niesen et al., 2005). TETs are involved in an active DNA demethy-
lation pathway, by converting 5mC to 5-hydroxymethylcytosine
(5hmC) (Seisenberger et al., 2013). These epigenetic mechanisms
critically regulate the differentiation of cells essential for the
development of the placenta and embryo (Table 1) (Ohgane et al.,
2002; Rugg-Gunn, 2012).
DNA METHYLATION MAINTAINS DISTINCT STEM CELL
LINEAGES
DNA methylation is involved in the distinction between the spe-
cialized cell lineages of pregnancy beginning from fertilization
until term (Hemberger, 2007; Nelissen et al., 2011; Xu et al.,
2011). The blastocyst has embryonic stem cell (ESC) lineages
in the inner cell mass, which will form the embryo, and tro-
phoblast stem cells in the trophectoderm of extra-embryonic
cells, which will develop into the placenta (Bischof and Irminger-
Finger, 2005). Histone modifications are thought to establish the
lineages of inner cell mass and trophectoderm (Nakanishi et al.,
2012) and then DNA methylation profiles “lock in” and main-
tain the lineages to create a barrier between them, i.e., to block
ESC from becoming trophoblast lineage (Ng et al., 2008; Senner,
2011; Oda et al., 2013). Both these lineages have the defining
feature of a distinctive global DNA methylation pattern (Senner
et al., 2012), so that the genome of the embryo is highly methy-
lated, whilst the genome of the placental trophectoderm lineage of
trophoblasts is globally hypomethylated (Hemberger, 2010; Xie
et al., 2013). In the trophoblasts, DNMT1 is down-regulated by
promoter methylation whereas DNMT3L is up-regulated, and in
turn activates both DNMT3A and DNMT3B (Table 1) (Chédin
et al., 2002; Hata et al., 2002; Suetake et al., 2004; Chen et al., 2005;
Novakovic et al., 2010; Haouzi et al., 2011). A complex biological
system, such as differentiating the trophoblast stem cell lineage,
builds in redundancy. If DNMT1 is not expressed then DNMT3A
and DNMT3B can substitute for DNMT1, if necessary, and main-
tain themethylation of DNA during cell proliferation (Liang et al.,
2002; Walton et al., 2011; Arand et al., 2012). In a mouse triple
knockout of DNMT1/3a/3b, extra-embryonic stem cells survived
and proliferated whereas ESC either died or with minimal CpG
methylation occasionally differentiated into trophoblast-like cells
(Li et al., 1992; Jackson et al., 2004; Tsumura et al., 2006; Ng et al.,
2008; Sakaue et al., 2010). However, knocking out DNMT3L dis-
rupted the placenta in mice (Hata et al., 2002; Arima et al., 2006;
Nelissen et al., 2011). Another feature of trophoblasts is the over-
all low level of 5hmC in the genome compared with the high level
of 5hmC in the ESC genome (Ito et al., 2010; Ruzov et al., 2011).
PLURIPOTENCY GENES AND TETs
To differentiate the trophoblast stem cell lineage from the ESC,
the pluripotency, transcription factor gene, POU5F1 (OCT4) is
hypermethylated and repressed in trophoblast stem cells (Hattori
et al., 2004; Li et al., 2007; Zhang et al., 2008; Zafarana et al.,
2009; Senner, 2011). There are more hypermethylated promot-
ers in trophoblast stem cells that silence pluripotency genes than
in ESC whereas in ESC pluripotency-related genes are generally
hypomethylated and expressed (Farthing et al., 2008). POU5F1
up-regulates TET1/2 in ESC to induce a high level of 5hmC and
therefore pluripotency (Ruzov et al., 2011), on the other hand
depletion of POU5F1 in trophoblast stem cells inhibits TET1/2
gene expression, which decreases 5hmC and pluripotency (Koh
et al., 2011). TET1/2 depletion hypermethylates specific genes
and if this occurs in ESC then pluripotency-related genes are
down-regulated and this tends to differentiate ESC into extra-
embryonic cells (Ficz et al., 2011; Koh et al., 2011; Williams
et al., 2012). In humans, mutated, inactive TET2 can lead to
cancers, such as hematopoietic cancer (Salker et al., 2011; Kudo
et al., 2012; Perez et al., 2012), yet TET1/2 knockout mice
can survive with reduced 5hmC. Perhaps the TET1/2 knockout
mice survive because TET3 was increased and substituted for
TET1/2, but the increased methylation compromised imprinted
genes, and there was also an increase in extra-embryonic stem
cells (Dawlaty et al., 2011, 2013). In a microarray study of
TET1 knockout mice, 221 genes, mainly developmental, were
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Table 1 | DNA methyltransferases (DNMTs) and TETs regulate specific key genes for differentiation and invasion.




↑DNMT3L, 3A, 3B (Arima et al., 2006; Novakovic
et al., 2010; Ficz et al., 2011; Haouzi et al., 2011;
Koh et al., 2011)
↑hCG, DNMT3L, C19MC miRNA, ELF5
↓POU5F1, DNMT1, Nanog, CYP24A1 (Hattori et al., 2004; Ng
et al., 2008; Novakovic et al., 2009; Tsai et al., 2009; Novakovic
et al., 2010; Senner, 2011; Grigoriu et al., 2011; Oda et al., 2013)




↑DNMT3A, 3B (Rahnama et al., 2006; Novakovic
et al., 2010)
↑Snail, Slug, REN, AGT, IL-1β? (Pringle et al., 2011; Chen et al.,
2005; Hashimoto et al., 2013)
↓E-cadherin, JUP, KRT7, RASSF1A, APC,
SFRP2, WIF1, EN1, maspin? (Sato et al., 2003; Rahnama et al.,
2006; Novakovic et al., 2008; Shi et al., 2012)
Epithelial endometrial ↓DNMT1, 3A, 3B (Rahnama et al., 2009) ↑E-cadherin, JUP (Rahnama et al., 2009)
Endometrial cancer ↓TET1
↑DNMT1, 3B (Beaulieu et al., 2002; Jin et al.,
2005; Liao et al., 2008; Cui et al., 2009; Hsu et al.,
2012; Kudo et al., 2012)
↓HAND2, E-cadherin, MLH1, HOXA11, miRNAs (Simpkins et al.,
1999; Baylin et al., 2001; Saito et al., 2003; Whitcomb et al.,
2003; Jones et al., 2013; Li et al., 2013)
Endometriotic ↑DNMT1, 3A, 3B (Wu et al., 2007) ↓HOXA10, PRB, miR-196b (Guo, 2009; Abe et al., 2013)
↑ERβ, NR5A1
Embryonic stem (ESC) -DNMT1, 3A, 3B, TET1, 2
(Li et al., 1992; Okano et al., 1999; Ficz et al., 2011;
Ruzov et al., 2011; Dawlaty et al., 2013; Oda et al.,
2013; Pastor et al., 2013)
↑syncytin-1, ELF5 (Hattori et al., 2004; Matousková et al., 2006;
Ng et al., 2008; Hemberger, 2010)
-POU5F1
AGT, angiotensinogen; APC, adenomatous polyposis coli; C19MC miRNA, chromosome 19 miRNA cluster; CTB, cytotrophoblast; CYP24A1, vitamin D
24-hydroxylase; DNMT, DNA methyltransferase; egEVT, endoglandular extravillous trophoblast; ELF5, E74-like factor 5 (ets domain transcription factor); EN1,
engrailed homeobox 1; enEVT, endothelial extravillous trophoblast; ERβ, estrogen receptor β; ESC, embryonic stem cell; HAND2, heart & neural crest deriva-
tives expressed 2; hCG, human chorionic gonadotropin; HOXA10/11, homeobox A10/11; IL-1β, interlukin 1β; iEVT, interstitial trophoblast; JUP, plakoglobin, gamma
catenin; KRT7, keratin 7; MLH1, mutL homolog 1; NR5A1, nuclear receptor subfamily 5, group A1 (steroidogenic factor 1); POU5F1, POU class 5 homeobox 1 (Oct4,
octomer binding protein 4); PRB, progesterone receptor B; RASSF1A, Ras association domain family 1A; REN, prorenin; SFRP2, secreted frizzle-related protein 2;
STB, syncytiotrophoblast; TET, ten-eleven translocation; WIF1, WNT inhibitory factor 1; ↓down-regulated; ↑over-expressed.
down-regulated (Dawlaty et al., 2011). Depleted TET1 in stem
cells up-regulate ELF5, the key trophoblast lineage-enforcing
gene, which is hypomethylated and expressed in trophoblast stem
cells but in ESC ELF5 must be methylated and silenced (Ng
et al., 2008; Senner and Hemberger, 2010; Hemberger, 2010;
Senner, 2011). If ESC are induced to express ELF5 then ESC can
become trophoblast-like (Roper and Hemberger, 2009; Koh et al.,
2011).
TROPHOBLAST STEM CELLS DIFFERENTIATE INTO
SPECIALISED TROPHOBLAST CELLS
DNMTs and TETs are involved in the differentiation and reg-
ulation of the specialized trophoblast cells in the placenta
(Table 1). Trophoblast stem cells are differentiated into prolifer-
ating, polarized epithelial cell cytotrophoblasts (CTB) and thence
into villous CTB of anchoring villi and non-proliferating syncy-
tiotrophoblasts (STB) (Figure 1) (Bischoff et al., 2000; Bischof
and Irminger-Finger, 2005; Ji et al., 2013). The down-regulation
of DNMT1, 3A and 3B in CTB hypomethylates the retroviral,
fusogenic-protein, syncytin-1, and the consequent high expres-
sion of syncytin-1 differentiates the CTBs into multi-nucleated,
single cell STB (Blond et al., 2000; Hemberger, 2010). Failure
of this differentiation into STBs may result in pre-eclampsia or
IUGR, with a different pattern of DNMTs and MBD proteins for
each condition (Baczyk et al., 2009; Ruebner et al., 2013). For
instance, the over-expression of DNMT3A will inhibit syncytin-1
gene expression and disrupt formation of STBs (Ruebner et al.,
2013). The other pathway for CTB progenitor differentiation,
from the anchoring villi columns, produces invasive intermedi-
ate trophoblasts (Fisher and Damsky, 1993), which invade the
endometrium as either interstitial EVTs (iEVT) or endovascular-
EVTs (enEVT) (Figure 1) (Pijnenborg et al., 1980). The inter-
mediate EVTs also possibly invade uterine glandular cells as
endoglandular EVTs (egEVT) in order to remodel and open up
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the uterine glands that can then secrete into the inter-villous space
(Fitzgerald et al., 2010; Moser et al., 2010). The iEVTs continue
to invade through the endometrium into the first third of the
myometrium and in the placental bed become mononuclear cell
aggregate and multi-nucleated giant cells (Fisher and Damsky,
1993; Al-Lamki et al., 1999). The enEVTs invade into the mater-
nal spiral arteries that have been prepared for EVT invasion by
decidual cells and uterine natural killer cells (Lash et al., 2010;
Hannon et al., 2012) and by replacing the vascular endothelial and
smooth muscle cells (Zhou et al., 1997), remodel these arteries
into low pressure, high volume vessels capable of delivering suffi-
cient maternal blood to the fetus through the placenta (Lockwood
et al., 1999). The morphology and function of iEVTs and enEVTs
are quite different to the STBs (Zhou et al., 1997).
EPITHELIAL CELLS TRANSFORM INTO A HIGHLY INVASIVE
MESENCHYMAL PHENOTYPE
To successfully become invasive EVTs, the CTBs undergo a tran-
sition from epithelial to highly invasive mesenchymal phenotype,
called EMT (epithelial-mesenchymal transition), similar to inva-
sive, metastatic cancer cells, except that EVTs are under strict
spatial and temporal regulation (Bischof and Irminger-Finger,
2005; Perry et al., 2010; Apps et al., 2011). The decidual cells
and extracellular matrix (ECM) inhibit the EVTs from invading
too deeply (Bischoff et al., 2000). Recently, a microarray of first
trimester trophoblasts identified over 3000 differentially regulated
genes in the transition from villous CTB to EVT and this included
ELF5 that was down-regulated in EVT (Apps et al., 2011). In
the EMT transition of epithelial CTBs into EVTs, the epithelial
marker genes of E-cadherin and keratin 7 (KRT7) are hyperme-
thylated and down-regulated (Rahnama et al., 2006; Chen et al.,
2013a). Similar to invasive cancer cells, the tumor suppressor
genes in EVTs are generally methylated, which down-regulates the
genes, such as APC, E-cadherin, and possibly maspin (Rahnama
et al., 2006; Wong et al., 2008; Shi et al., 2012). Two other EMT
differentiation proteins, Snail and Slug, that are also involved
in cancer and down-regulate E-cadherin, are up-regulated by
hypomethylation in trophoblast cell-lines and differentiate CTBs
into EVTs (Table 1) (Chen et al., 2013b). In endometrial cancer,
an invasive phenotype is produced by an aberrant over-expression
of DNMT1 and DNMT3B that down-regulates E-cadherin (Chan
et al., 2003; Saito et al., 2003; Jin et al., 2005; Liao et al., 2008).
In a similar epithelial-based invasive pathology, of endometriosis,
DNMT1, 3A, 3B are over-expressed in the ectopic endometrial
cells (Wu et al., 2007). DNMT1, 3A, 3B hypermethylate and
down-regulate PRB, the progesterone receptor B, but there is no
change in E-cadherin levels and so there is no EMT differentia-
tion (Shaco-Levy et al., 2008). Concomitantly in endometriosis,
DNMT1, 3A, 3B hypermethylate and down-regulate the anti-
invasive HOXA10 gene expression in the eutopic endometrium
(Chu et al., 2004; Wu et al., 2005; Santamaria et al., 2012).
CHROMATIN CONDENSATION CORRELATES WITH
INVASIVENESS
Perhaps EVTs have chromatin condensation to enable migration
and invasion? Although cancer cells generally have partially con-
densed chromatin between that of normal proliferative and senes-
cent cells (Oh et al., 2013) there is a correlation between increased
DNA hypermethylation, and therefore chromatin condensation,
and increased invasiveness, which is essential during metastasis
for the cancer cell intravasion into and extravasion out of blood
vessels (Dufer et al., 2000; Fu et al., 2012). During cell migra-
tion the condensed chromatin allows the nuclei to be squeezed
to fit through narrow gaps between cells (Gerlitz and Bustin,
2010; Fu et al., 2012). Constitutive heterochromatin is invariably
condensed but when necessary the facultative heterochromatin
can be condensed for invasion (Trojer and Reinberg, 2007).
Chromatin condensation has also been observed in sperm, leuko-
cytes, glioma cells, and neurons (Hammadeh et al., 1998; Gerlitz
and Bustin, 2010). If cells are differentiated into invasive pheno-
types then there is a tendency for the epigenetic mechanisms of
DNAmethylation and histonemodification to condense the chro-
matin (Gerlitz and Bustin, 2010). When treatments of the histone
methyltransferase inhibitor (5′-deoxy-5′-methyl-thioadenosine),
HDAC inhibitors, or TETs were applied to invasive cell types
then those cells decondensed the chromatin and invasiveness was
inhibited (Gerlitz and Bustin, 2010; Fu et al., 2012; Song et al.,
2013). In other cell types over-expression of TET increases 5hmC,
which decreases 5mC (hypomethylation) and decondenses chro-
matin, so possibly the lack of TET expression in EVTs encourages
an invasive phenotype by condensing the chromatin (Wanunu
et al., 2010; Hsu et al., 2012; Pfeifer et al., 2013).
DNA METHYLATION REGULATES SPECIFIC GENES
Trophoblast genomes are globally hypomethylated, predomi-
nantly in repetitive DNA elements and intergenic regions, relative
to somatic tissue genomes, yet concomitantly specific genes in
trophoblasts are hypermethylated (generally tumor suppressor
genes) to ensure EMT into EVTs and induce invasiveness similar
to metastatic cancer cells (Gama-Sosa et al., 1983; Ehrlich, 2009;
Apps et al., 2011; Novakovic and Saffery, 2012; Shen et al., 2012).
Specific genes that are down-regulated by DNA methylation in
EVTs have been identified and include E-cadherin, plakoglobin
(JUP), KRT7, DNMT1, and five Wnt signaling inhibitors APC,
SFRP2, RASSF1A, EN1, and WIF1 (Table 1) (Rahnama et al.,
2006; Chiu et al., 2007; Novakovic et al., 2008, 2010; Guilleret
et al., 2009; Chen et al., 2013a). The increased Wnt signaling
stimulates β-catenin accumulation in the nucleus, and that pro-
motes EVT invasiveness (Pollheimer et al., 2006). Sometimes
there is hypomethylation and up-regulation of specific genes
in EVTs, such as the renin-angiotensin system genes (RAS)
(Wang et al., 2012). In the immortalized EVT-like cell-line,
HTR8/SVneo, treatments of both cyclic AMP and 5-aza-2′-
deoxycytidine (AZA), an inhibitor of DNMTs and DNA methyla-
tion, up-regulated prorenin (REN), and angiotensinogen (AGT)
(Wang et al., 2013b). RAS genes regulate EVT invasion and vascu-
lar remodeling and it has been suggested that aberrant expression
could be linked to pre-eclampsia and IUGR (Williams et al., 2010;
Pringle et al., 2011).
HYPERMETHYLATION OF SPECIFIC GENES CONCOMITANT
WITH GLOBAL HYPOMETHYLATION
The question that has long been asked has been how do spe-
cific genes become hypermethylated and silenced in cells that
otherwise have globally hypomethylated genomes, such as in can-
cer and now here in trophoblasts (Caiafa and Zampieri, 2005)?
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Global hypomethylation generally consists of vast hypomethy-
lated regions of the genome that are depleted of genes whereas
hypermethylated genes, such as tumor suppressor genes, have
methylated promoters (Shen et al., 2012; Varley et al., 2013). A
mouse tumor model showed that a functional DNMT3a deter-
mined that genomic hypomethylation was restricted to regional
rather than the uniformly widespread hypomethylation through-
out the genome that occurs in DNMT3a deficient mice (Raddatz
et al., 2012). (This difference in DNMT3A expression could
explain the possible difference between STB and EVT genomic
hypomethylation.) DNA methylation should not be regarded as
static in cancer because genomic hypomethylation and hyper-
methylation of specific genes increase progressively as the tumor
increases in malignancy (Jones and Baylin, 2007; Esteller, 2008;
Ehrlich, 2009) and even then not all tumor suppressor genes are
hypermethylated (Hamilton et al., 2005). Regulation of hyper-
methylation of specific genes and genomic hypomethylation in
cancer, and presumably in trophoblasts, is not dependent solely
on DNMTs but involves the combined action with histone modi-
fication (Freitag and Selker, 2005; Esteller, 2008; Ehrlich, 2009),
ncRNA (Kulis and Esteller, 2010), and TETs (Hsu et al., 2012;
Williams et al., 2012). The inactivation of TETs can be involved
in the targeted hypermethylation and silencing of specific tumor
suppressor genes (Hsu et al., 2012; Williams et al., 2012). There
is ample evidence that DNMTs interact with HDACs (Fuks et al.,
2000; Bachman et al., 2001; Geiman et al., 2004) and transcrip-
tion factors (Di Croce et al., 2002; Suzuki et al., 2005; Hervouet
et al., 2009; Pavlopoulou and Kossida, 2010; Yuen et al., 2013),
often in complexes, to target the methylation of specific genes
(Robertson et al., 2000; Fuks et al., 2001; Zhang et al., 2005).
Specific genes can be expressed in specific tissues (Schroeder et al.,
2013), for example, syncytin-1 is highly expressed and tissue spe-
cific to the placenta (Mi et al., 2000; Matousková et al., 2006;
Muir et al., 2006) however aberrant hypomethylation and expres-
sion of the syncytin-1 gene in the brain has been proposed to
contribute to multiple sclerosis (Perron et al., 1997; Mattson and
Taub, 2004).
FACTORS THAT REGULATE THE DNMTs
So what factors regulate the DNMTs? DNMTs can be regu-
lated by steroid hormones (Cui et al., 2009; Yamagata et al.,
2009; Vincent et al., 2011; Logan et al., 2013) growth factors
(Shafiei et al., 2008), cell cycle regulators (Lin et al., 2010),
viruses (Flanagan, 2006; Shamay et al., 2006), and cytokines
(Karmakar and Das, 2002; Braconi et al., 2010). The cytokines of
IL-1β, IL-6, VEGF, and cytokine-activated HIF-1α are involved
in trophoblast invasion (Karmakar and Das, 2002; Dubinsky
et al., 2010). IL-1β can regulate DNMTs, suppress methylation,
reduce E-cadherin, stimulate MMP9 [crucial for EVT invasion
(Whiteside et al., 2001)] and positively correlates with invasive-
ness (Librach et al., 1994; Karmakar and Das, 2004; Hashimoto
et al., 2010; Nakano et al., 2013). Conversely, IL-1β can be methy-
lated and regulated at a single CpG, −299 bp (Hashimoto et al.,
2013). DNMTs can also both be regulated by and interact with the
cell cycle regulators p53/Sp1, MDM, pRb, and E2F (Robertson
et al., 2000; Kimura et al., 2003; Esteve et al., 2005; Lin et al.,
2010).
TETs
The TETs are down-regulated in the placenta, just like in can-
cer cells, which means 5hmC is reduced in the DNA of cells and
the reduction in gene body-associated 5hmC generally inhibits
gene expression (Ficz et al., 2011; Lian et al., 2012; Pfeifer
et al., 2013). TET1 partly suppresses invasion in cancer by bind-
ing to TIMP2/3 and demethylating the promoters to activate
TIMP2/3, and in turn down-regulates MMP expression (Hsu
et al., 2012). Conversely, depletion of TET1 hypermethylates and
silences TIMP2/3 (Hsu et al., 2012). The TETs are the proposed
active DNA demethylases that convert 5mC to 5hmC, and then
can continue that pathway so that eventually 5mC is converted
to cytosine (Seisenberger et al., 2013). There has been a sugges-
tion that oxygen regulation of gene expression is mediated by TET
conversion of 5mC to 5hmC (Thalhammer et al., 2011). Recently
it has been reported that under redox conditions DNMT3A and
DNMT3B, as well as being methylases, can demethylate DNA,
such as in cancer (Kangaspeska et al., 2008; Metivier et al., 2008;
Chen et al., 2012). Perhaps DNMT3A and DNMT3B can, under
hypoxic conditions in the endometrium, aberrantly demethylate
DNA in EVTs?
CONCLUSION
If any of the epigenetic enzymes of DNMTs, TETs, HDACs, and
ncRNAs are dysfunctional in EVTs then the differentiation and
invasiveness of EVTsmay be compromised (Rugg-Gunn, 2012; Fu
et al., 2013; Ji et al., 2013; Mouillet et al., 2013). Environmental
factors, such as diet or oxygen stress, can disrupt epigenetic regu-
lation of trophoblasts (Novakovic and Saffery, 2012), for example,
hypoxia of <1% oxygen in STBs can affect the AP-1 transcrip-
tion factor and adversely disrupt the function of DNMT1 (Yuen
et al., 2013). Poorly functioning trophoblasts fail to provide an
adequate blood supply in circulation through the placenta to the
fetus and this has been linked to pathologies of pregnancy such as
preeclampsia and IUGR (Maccani and Carmen, 2009; Kokkinos
et al., 2010). Future work will attempt to understand the interac-
tive nature of all the epigenetic mechanisms together and their
effect on the complex biological system of trophoblast differ-
entiation and EVT invasion in normal as well as pathological
conditions.
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